Press Releases

Date Title and Summary
Toggle Summary Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer
SUNNYVALE, Calif. , May 17, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Sandeep Chalke has joined the company as senior vice president, chief commercial officer effective May 16, 2022 . Mr. Chalke will have responsibility for the global commercial, product
Toggle Summary Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
SUNNYVALE, Calif. , May 17, 2012 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the appointment of Richard Pettingill , LFACHE as a member of the company's Board of Directors effective May 11, 2012 .
Toggle Summary Accuray Appoints Renowned Medical Device Industry Executive Jim Dennison as Senior Vice President of Global Quality and Regulatory Affairs
SUNNYVALE, Calif. , Nov. 12, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Jim Dennison as its senior vice president of global quality and regulatory affairs, effective immediately. Mr. Dennison is an accomplished quality assurance and regulatory affairs
Toggle Summary Accuray Appoints Peter Fine to Board of Directors
SUNNYVALE, Calif., June 29, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the appointment of Peter Fine as a member of the company's Board of Directors effective June 28, 2010.
Toggle Summary Accuray Appoints Mike Leischer Vice President and General Manager, Americas Region
SUNNYVALE, Calif. , Oct. 19, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Mike Leischer as its vice president and general manager, Americas (AMS) region, effective immediately. In this role, he will provide leadership of the AMS region commercial teams,
Toggle Summary Accuray Appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer
SUNNYVALE, Calif. , Oct. 21, 2019 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) announced today that Suzanne Winter has joined the company as Senior Vice President, Chief Commercial Officer effective October 21, 2019 . Ms. Winter will have global responsibility for the commercial function
Toggle Summary Accuray Appoints Jean-Philippe Pignol, M.D., Ph.D. as Chief Medical & Technology Officer
SUNNYVALE, Calif. , April 26, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY ) announced today the appointment of Jean-Philippe Pignol , M.D., Ph.D. as its chief medical & technology officer, effective as of April 15, 2021 . In this new role, Dr.
Toggle Summary Accuray Appoints Jack Goldstein, Ph.D. to Board of Directors
SUNNYVALE, Calif., May 26, 2010 /PRNewswire via COMTEX/ --Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the appointment of Jack Goldstein, Ph.D. as a member of the company's Board of Directors, effective immediately. Dr.
Toggle Summary Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors
SUNNYVALE, Calif. , Sept. 12, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) strengthened its Board of Directors with the appointment of James (Jim) M. Hindman , effective as of September 6, 2019 , and expanding the company's Board to nine members. Mr.
Toggle Summary Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors
SUNNYVALE, Calif. , Feb. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott , M.D., MBA to the company's Board of Directors, effective as of February 12, 2021 . Dr. Scott brings significant experience as a physician executive with

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.